Centrus Energy (LEU) has signed a contract with the U.S. Department of Energy that could reach US$1.07b, moving its High Assay Low Enriched Uranium business from demonstration work into commercial scale production.

The contract news lands at a time when Centrus Energy's 1 month share price return is down 18.6% and its year to date share price return is down 40.5%. However, the 3 year total shareholder return is more than 4x and the 5 year total shareholder return is more than 5x, suggesting long term holders have still seen very large gains while shorter term momentum has recently faded.

If this HALEU contract has you thinking more broadly about nuclear fuel and power, it could be worth scanning other nuclear focused plays through the 89 nuclear energy infrastructure stocks

So with Centrus Energy shares down sharply this year despite a US$1.07b HALEU contract in hand, and trading at a sizeable discount to analyst targets and intrinsic estimates, is this a genuine opportunity, or is the market already looking through to future growth?

Most Popular Narrative: 73.4% Undervalued

The most followed narrative on Centrus Energy currently anchors on a fair value of $609.90 per share versus the last close of $162.13, implying a wide valuation gap that some investors are trying to explain through its role in the U.S. nuclear fuel system.

Centrus Energy is one of those rare companies whose importance becomes clearer the deeper you look into the machinery of U.S. law, national security, and nuclear policy. In a sector defined by scarcity, Centrus isn’t just another uranium company; it is the only U.S. company legally authorized to enrich uranium for the federal government, a distinction rooted directly in federal statute.

Read the complete narrative. Read the complete narrative.

Want to understand why this narrative supports such a high price tag for Centrus Energy? It leans heavily on long term enrichment demand, higher margins and a premium profit multiple that would surprise many nuclear fuel investors.

Result: Fair Value of $609.90 (UNDERVALUED)

However, this Centrus Energy narrative could be challenged if future U.S. nuclear policy shifts reduce HALEU demand, or if new enrichment competitors eventually meet government requirements.

Another View: Centrus Energy Looks Expensive on Earnings

The user narrative leans on a fair value of $609.90 per Centrus Energy share, but the current P/E of 52.6x is far above the Oil and Gas industry average of 12.8x and a fair ratio of 9.6x. That gap suggests meaningful valuation risk if sentiment or growth expectations cool.

See what the numbers say about this price in our valuation breakdown, starting with the See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With sentiment around Centrus Energy clearly split between risk and reward, it makes sense to scan the data yourself and move quickly to your own view. A good place to start is with a closer look at the 1 key reward and 5 important warning signs.

Looking for more Centrus Energy style investment ideas?

If Centrus Energy has sharpened your focus on where capital could work harder, do not stop here. Your next move across other opportunities might matter even more.

• Target potential upside in companies that combine quality with pricing power by scanning the 42 high quality undervalued stocks.
• Strengthen your income stream by reviewing the 7 dividend fortresses built around higher yielding, resilient payers.
• Prioritise capital preservation and steadier journeys by filtering for companies in the 75 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.